BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16761999)

  • 1. Clinical and HLA phenotypes of type 1 autoimmune hepatitis in North American patients outside DR3 and DR4.
    Czaja AJ; Carpenter HA; Moore SB
    Liver Int; 2006 Jun; 26(5):552-8. PubMed ID: 16761999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis.
    Czaja AJ; Donaldson PT
    Am J Gastroenterol; 2002 Aug; 97(8):2051-7. PubMed ID: 12190176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis.
    Czaja AJ; Donaldson PT; Lohse AW
    Am J Gastroenterol; 2002 Feb; 97(2):413-9. PubMed ID: 11866281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors.
    Donaldson PT; Doherty DG; Hayllar KM; McFarlane IG; Johnson PJ; Williams R
    Hepatology; 1991 Apr; 13(4):701-6. PubMed ID: 2010165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of HLA DRB103-DRB104 in type 1 autoimmune hepatitis.
    Montano-Loza AJ; Carpenter HA; Czaja AJ
    Liver Int; 2006 Dec; 26(10):1201-8. PubMed ID: 17105585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of a genetic basis for the different geographic occurrences of liver/kidney microsomal antibody type 1 in hepatitis C.
    Muratori P; Czaja AJ; Muratori L; Granito A; Guidi M; Ferri S; Volta U; Mantovani W; Pappas G; Cassani F; Lenzi M; Bianchi FB
    Dig Dis Sci; 2007 Jan; 52(1):179-84. PubMed ID: 17160474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent autoimmune hepatitis after orthotopic liver transplantation.
    González-Koch A; Czaja AJ; Carpenter HA; Roberts SK; Charlton MR; Porayko MK; Rosen CB; Wiesner RH
    Liver Transpl; 2001 Apr; 7(4):302-10. PubMed ID: 11303289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and significance of antibodies to cyclic citrullinated peptide in type 1 autoimmune hepatitis.
    Montano-Loza A; Czaja AJ; Carpenter HA; Piette A; Murphy D; Shums Z; Burlingame R; Norman GL
    Autoimmunity; 2006 Jun; 39(4):341-8. PubMed ID: 16891223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA and autoimmune endocrine disease 1985.
    Farid NR; Thompson C
    Mol Biol Med; 1986 Feb; 3(1):85-97. PubMed ID: 3485759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on the association between maternal-infantile vertical transmission of hepatitis B virus and human leukocyte antigen DR gene domain].
    Liu HY; Kong BH; Luo X; Xu YP; Dai MS; Jiang S
    Zhonghua Fu Chan Ke Za Zhi; 2003 Oct; 38(10):599-603. PubMed ID: 14728861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of HLA DR4 in type 1 autoimmune hepatitis.
    Czaja AJ; Carpenter HA; Santrach PJ; Moore SB
    Gastroenterology; 1993 Nov; 105(5):1502-7. PubMed ID: 8224654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The HLA-DR phenotype in Croatian children with gluten enteropathy].
    Jurcić Z; Brkljacić-Surkalović L; Kerhin-Brkljacić V; Kastelan A; Miskić-Musa M; Zobenica M; Pavlović S
    Lijec Vjesn; 1998 Sep; 120(9):273-7. PubMed ID: 10099667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual association of HLA DR2 and DR3 with primary sclerosing cholangitis.
    Donaldson PT; Farrant JM; Wilkinson ML; Hayllar K; Portmann BC; Williams R
    Hepatology; 1991 Jan; 13(1):129-33. PubMed ID: 1988334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR4, DR13(6) and the ancestral haplotype A1B8DR3 are associated with ANCA-associated vasculitis and Wegener's granulomatosis.
    Stassen PM; Cohen-Tervaert JW; Lems SP; Hepkema BG; Kallenberg CG; Stegeman CA
    Rheumatology (Oxford); 2009 Jun; 48(6):622-5. PubMed ID: 19336578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic distinctions between autoimmune hepatitis in Italy and North America.
    Muratori P; Czaja AJ; Muratori L; Pappas G; Maccariello S; Cassani F; Granito A; Ferrari R; Mantovani V; Lenzi M; Bianchi FB
    World J Gastroenterol; 2005 Mar; 11(12):1862-6. PubMed ID: 15793882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis.
    Czaja AJ; Carpenter HA
    Hepatology; 2004 Jun; 39(6):1631-8. PubMed ID: 15185304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigens-DR3 and/or DR4, except when associated with type I autoimmune polyglandular syndrome.
    Maclaren NK; Riley WJ
    J Clin Endocrinol Metab; 1986 Mar; 62(3):455-9. PubMed ID: 3484749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-locus involvement in the association of human leukocyte antigen with the extrahepatic manifestations of autoimmune chronic active hepatitis.
    Marcos Y; Fainboim HA; Capucchio M; Findor J; Daruich J; Reyes B; Pando M; Theiler GC; Méndez N; Satz ML
    Hepatology; 1994 Jun; 19(6):1371-4. PubMed ID: 8188167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of TNF microsatellite marker a and HLA-DR-DQ in diabetes mellitus-a study in 609 Swedish subjects.
    Törn C; Hillman M; Sanjeevi CB; Landin-Olsson M
    Hum Immunol; 2006 Jul; 67(7):527-34. PubMed ID: 16829307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse.
    Montano-Loza AJ; Carpenter HA; Czaja AJ
    Am J Gastroenterol; 2007 May; 102(5):1005-12. PubMed ID: 17319926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.